Evidence map›Paper›PMID 32269457›Full record

ArticleEthnicity & disease2020

Why African Americans say "No": A Study of Pharmacogenomic Research Participation.

Mohammed Nooruddin, Courtney Scherr, Paula Friedman, Ramesh Subrahmanyam, Jeff Banagan, Diana Moreno, Myurani Sathyanarayanan, Edith Nutescu, Tharani Jeyaram, Mary Harris and 6 more

Abstract read
In one paragraph

Article in Ethnicity & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Fecal transplantation for treatment of inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mohammed NooruddinDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Courtney ScherrDepartment of Communication Studies, Northwestern University, Chicago, IL.
Paula FriedmanDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Ramesh SubrahmanyamWashington DC VA Medical Center, Washington, DC.
Jeff BanaganWashington DC VA Medical Center, Washington, DC.
Diana MorenoDepartment of Pharmacy Systems, Outcomes and Policy and Personalized Medicine Program, University of Illinois, College of Pharmacy, Chicago, IL.
Myurani SathyanarayananDepartment of Pharmacy Systems, Outcomes and Policy and Personalized Medicine Program, University of Illinois, College of Pharmacy, Chicago, IL.
Edith NutescuDepartment of Pharmacy Systems, Outcomes and Policy and Personalized Medicine Program, University of Illinois, College of Pharmacy, Chicago, IL.
Tharani JeyaramDepartment of Medicine, Section of Hospital Medicine, University of Chicago, Chicago, IL.
Mary HarrisDepartment of Medicine, Section of Hospital Medicine, University of Chicago, Chicago, IL.
Honghong ZhangDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Adriana RodriguezDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Mohammed ShaazuddinDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Minoli PereraDepartment of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Matthew TuckWashington DC VA Medical Center, Washington, DC.
ACCOuNT Investigators

Funding

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translationU54MD010723 · NIMHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MELTZER, DAVID O, PERERA, MINOLI A · 2016 to 2020
$9.5M
NIMHD NIH HHS U54 MD010723
6 · The paper itself

Abstract

Objective: To identify reasons for nonparticipation by African Americans in cardiovascular pharmacogenomic research. Design: Prospective, open-ended, qualitative survey. Setting: Research staff approached patients eligible for the Discovery Project of The African American Cardiovascular pharmacogenomics CONsorTium in the inpatient or outpatient setting at four different institutions during September and October 2018. Participants: Potential Discovery Project participants self-identified as African American, aged >18 years, were on one of five cardiovascular drugs of interest, and declined enrollment in the Discovery Project. Main Outcome Measures: Reasons for nonparticipation. Methods: After declining participation in the Discovery Project, patients were asked, "What are your reasons for not participating?" We analyzed their responses using a directed content analytic approach. Ultimately, responses were coded into one of nine categories and analyzed using descriptive statistics. Results: Of the 194 people approached for the Discovery Project during an eight-week period, 82 declined participation and provided information for this study. The most common reason for refusal was concern about the amount of blood drawn (19.5%). The next most common reasons for refusal to participate included concerns about genetic testing (14.6%) and mistrust of research (12.2%). Across study sites, significantly more patients enrolled in the inpatient than outpatient setting (P<.001). Significantly more women and younger individuals declined participation due to concerns about genetic testing and too little compensation (P<.05). Conclusions: Collection of blood samples and concerns about genetic testing are obstacles for the recruitment of African Americans to pharmacogenomics studies. Efforts to overcome these barriers to participation are needed to improve representation of minorities in pharmacogenomic research. Enrolling participants from inpatient populations may be a solution to bolster recruitment efforts.

Indexed as

AdultAttitude to HealthBlack or African AmericanFemaleHumansMaleMiddle AgedMinority GroupsPatient ParticipationPharmacogeneticsProspective StudiesResearch SubjectsSocial PerceptionYoung AdultAfrican AmericansHealth AttitudesHealth KnowledgeHealth LiteracyHealth Practice/EthnologyPharmacogenomic TestingPsychologyResearch Participants

Identifiers

PMID32269457
PMCPMC7138442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.